1. Home
  2. CIVB vs TECX Comparison

CIVB vs TECX Comparison

Compare CIVB & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$22.95

Market Cap

433.8M

Sector

Finance

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$20.12

Market Cap

366.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIVB
TECX
Founded
1884
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
433.8M
366.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
CIVB
TECX
Price
$22.95
$20.12
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$25.40
$80.40
AVG Volume (30 Days)
84.4K
223.4K
Earning Date
01-29-2026
11-06-2025
Dividend Yield
2.97%
N/A
EPS Growth
33.31
N/A
EPS
2.66
N/A
Revenue
$163,095,000.00
N/A
Revenue This Year
$18.06
N/A
Revenue Next Year
$11.12
N/A
P/E Ratio
$8.61
N/A
Revenue Growth
11.28
N/A
52 Week Low
$17.47
$13.70
52 Week High
$25.59
$61.07

Technical Indicators

Market Signals
Indicator
CIVB
TECX
Relative Strength Index (RSI) 51.55 52.04
Support Level $22.27 $17.77
Resistance Level $24.00 $19.64
Average True Range (ATR) 0.66 1.37
MACD 0.09 -0.15
Stochastic Oscillator 54.64 57.36

Price Performance

Historical Comparison
CIVB
TECX

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: